Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Medvasc Aktiebolag |
| Country | Sweden |
| Start Date | May 01, 2024 |
| End Date | Jun 30, 2024 |
| Duration | 60 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2024-00861_Vinnova |
Purpose and goal:
The goal of the project "Understanding reimbursement in the USA" - to develop a cost reimbursement analysis and a cost reimbursement strategy with the help of external expertise has been achieved.
Also the purpose - to have strengthened the company´s competitiveness at the end of the project with the help of the right knowledge of the payment system has been achieved. Expected results and effects:
At the end of the project period, we expected that the process of developing a cost reimbursement analysis and a cost reimbursement strategy would give us an increased understanding and influence our future go-to-market strategy. We can now state that the expected outcomes have been achieved. Approach and implementation:
The project was carried out in collaboration between the CEO and an external consultant who jointly delivered/implemented the following work package: AP-1 title: Review of product profile for Solutio to understand product-specific nuances
AP-2 title: Secondary research into analogous product launches in the US and relevant coverage policies/adjudications by CMS AP-3 title: Quick interviews with EVERSANA SMEs on coding & reimbursement to assess expected access and reimbursement AP-4 title: Development of strategic next steps and synthesis of findings into a presentable report
Medvasc Aktiebolag
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant